POLITICO @politico
The FDA's acting commissioner has called for a watchdog probe of her agency's dealings with the drugmaker Biogen prior to last month's accelerated approval of the company's new Alzheimer's therapy https://t.co/jDj1IamqT8 — PolitiTweet.org